Skip to main content
. 2018 Jan 29;3(1):e000288. doi: 10.1136/esmoopen-2017-000288

Table 3.

Adverse events other than renal toxicities according to Common Terminology Criteria for Adverse Events V.4

n=46 G1 (%) G2 (%) G3 (%) Total (%)
Any adverse event
Fever 10 (22) 0 0 10 (22)
Fatigue 14 (30) 3 (7) 0 17 (37)
Body weight loss 6 (13) 0 0 6 (13)
Anorexia 18 (39) 12 (26) 2 (4) 32 (70)
Nausea 17 (37) 12 (26) 1 (2) 30 (65)
Vomiting 5 (11) 1 (2) 0 6 (13)
Constipation 23 (50) 1 (2) 0 24 (52)
Diarrhoea 5 (11) 1 (2) 2 (4) 8 (17)
Stomatitis 2 (4) 0 0 2 (4)
Febrile neutropaenia 0 0 3 (7) 3 (7)
Alopecia 6 (13) 4 (9) 0 10 (22)

No G4 or severe adverse events were observed.